AAF
ALNY icon

Andra AP-fonden’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.25M Sell
6,900
-9,900
-59% -$3.23M 0.03% 340
2025
Q1
$4.54M Sell
16,800
-11,100
-40% -$3M 0.07% 293
2024
Q4
$6.57M Buy
27,900
+15,200
+120% +$3.58M 0.11% 265
2024
Q3
$3.49M Buy
12,700
+9,600
+310% +$2.64M 0.05% 333
2024
Q2
$753K Buy
+3,100
New +$753K 0.01% 377
2024
Q1
Sell
-35,500
Closed -$6.8M 368
2023
Q4
$6.8M Buy
35,500
+1,000
+3% +$191K 0.36% 132
2023
Q3
$6.11M Sell
34,500
-6,000
-15% -$1.06M 0.36% 127
2023
Q2
$7.69M Sell
40,500
-4,700
-10% -$893K 0.19% 214
2023
Q1
$9.05M Sell
45,200
-10,400
-19% -$2.08M 0.24% 147
2022
Q4
$13.2M Buy
55,600
+7,000
+14% +$1.66M 0.4% 19
2022
Q3
$9.73M Buy
48,600
+6,500
+15% +$1.3M 0.32% 58
2022
Q2
$6.14M Buy
+42,100
New +$6.14M 0.18% 256
2021
Q4
$4.82M Buy
28,400
+8,500
+43% +$1.44M 0.1% 419
2021
Q3
$3.76M Buy
19,900
+2,500
+14% +$472K 0.08% 488
2021
Q2
$2.95M Buy
17,400
+1,400
+9% +$237K 0.06% 532
2021
Q1
$2.26M Sell
16,000
-2,500
-14% -$353K 0.05% 537
2020
Q4
$2.4M Buy
18,500
+4,300
+30% +$559K 0.05% 552
2020
Q3
$2.07M Sell
14,200
-23,900
-63% -$3.48M 0.06% 562
2020
Q2
$5.64M Buy
38,100
+3,700
+11% +$548K 0.16% 280
2020
Q1
$3.74M Buy
34,400
+20,000
+139% +$2.18M 0.14% 388
2019
Q4
$1.66M Buy
14,400
+11,600
+414% +$1.34M 0.05% 626
2019
Q3
$225K Buy
+2,800
New +$225K 0.01% 657
2019
Q2
Sell
-5,600
Closed -$523K 658
2019
Q1
$523K Buy
+5,600
New +$523K 0.02% 635
2018
Q3
Sell
-12,800
Closed -$1.26M 637
2018
Q2
$1.26M Sell
12,800
-1,900
-13% -$187K 0.03% 623
2018
Q1
$1.75M Buy
14,700
+12,800
+674% +$1.52M 0.05% 622
2017
Q4
$241K Buy
+1,900
New +$241K 0.01% 672